SCHEMBL19685683

SCHEMBL19685683

Cc1coc2cc(N3c4ccc(F)cc4-c4ccccc4Oc4ccccc4-c4cc(F)ccc43)ccc2c1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.38
ALDH1A1 P00352 5/20 0.38
HPGD P15428 4/20 0.38
HSD17B10 Q99714 3/20 0.38
USP2 O75604 2/20 0.38
SMN1; SMN2 Q16637 4/20 0.34
CYP3A4 P08684 2/20 0.34
GLA P06280 1/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
GAA P10253 1/20 0.34
PPARG P37231 1/20 0.34
PPARD Q03181 1/20 0.34
PPARA Q07869 1/20 0.34
KCNA3 P22001 3/20 0.33
CYP11B1 P15538 2/20 0.32
CYP11B2 P19099 2/20 0.32
GRM1 Q13255 2/20 0.32
NR1H2 P55055 1/20 0.32
NR1H3 Q13133 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19685949 0.90 ALDH1A1 (0.40) KDM4EALDH1A1HPGDHSD17B10USP2
SCHEMBL19685948 0.89 ALDH1A1 (0.43) KDM4EALDH1A1HPGDHSD17B10USP2
SCHEMBL19685682 0.83 KDM4E (0.32) KDM4EALDH1A1HPGDHSD17B10USP2
SCHEMBL19685686 0.82 MAOB (0.39) KDM4EALDH1A1HPGDHSD17B10USP2
SCHEMBL19685968 0.81 ATM (0.36) KDM4EALDH1A1SMN1; SMN2NR1H2NR1H3
SCHEMBL19686088 0.80 BRD4 (0.38) KDM4EALDH1A1SMN1; SMN2NR1H2NR1H3
SCHEMBL19685877 0.79 MAPK8 (0.37) NPC1RAB9ANR1H2NR1H3MEN1
SCHEMBL19686118 0.76 PTPN1 (0.35) KDM4EALDH1A1MAOBPTPN1PDE10A
SCHEMBL19685880 0.76 LMNA (0.38) KDM4EALDH1A1SMN1; SMN2GLANPC1
SCHEMBL19685674 0.76 KDM4E (0.36) KDM4EALDH1A1HPGDHSD17B10USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2017-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME CYC1, CCNA1, CYCS KDM4E 1138/4885ALDH1A1 572/4885HPGD 901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.